Jinjun Cheng

4.1k total citations
24 papers, 377 citations indexed

About

Jinjun Cheng is a scholar working on Pathology and Forensic Medicine, Hematology and Molecular Biology. According to data from OpenAlex, Jinjun Cheng has authored 24 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Jinjun Cheng's work include Acute Myeloid Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Viral-associated cancers and disorders (4 papers). Jinjun Cheng is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Viral-associated cancers and disorders (4 papers). Jinjun Cheng collaborates with scholars based in United States, China and Canada. Jinjun Cheng's co-authors include Jing Ma, Guangchun Song, James R. Downing, Charles G. Mullighan, Jinghui Zhang, Xiaoping Su, Lawrence M. Pfeffer, Michelle Sims, Chun Cai and Zhongling Cai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and eLife.

In The Last Decade

Jinjun Cheng

20 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jinjun Cheng United States	10	171	155	87	78	61	24	377
Caterina Matteucci Italy	15	219 1.3×	306 2.0×	40 0.5×	168 2.2×	65 1.1×	49	604
Angela Minervini Italy	14	221 1.3×	214 1.4×	139 1.6×	90 1.2×	62 1.0×	38	483
Mervat M. Khorshied Egypt	12	98 0.6×	73 0.5×	29 0.3×	32 0.4×	44 0.7×	46	342
C. Fonatsch Germany	8	207 1.2×	213 1.4×	31 0.4×	74 0.9×	64 1.0×	17	401
Massimiliano De Bortoli Italy	10	183 1.1×	78 0.5×	55 0.6×	27 0.3×	144 2.4×	20	412
Victor Ng United States	9	158 0.9×	72 0.5×	65 0.7×	61 0.8×	82 1.3×	17	393
Manabu Kusakabe Japan	11	149 0.9×	103 0.7×	45 0.5×	14 0.2×	58 1.0×	27	304
Jodie Ulaszek United States	6	154 0.9×	106 0.7×	25 0.3×	23 0.3×	64 1.0×	9	329
Anke K. Bergmann Germany	12	244 1.4×	113 0.7×	61 0.7×	98 1.3×	77 1.3×	34	524
Rika Kanezaki Japan	11	198 1.2×	163 1.1×	40 0.5×	69 0.9×	47 0.8×	19	387

Countries citing papers authored by Jinjun Cheng

Since Specialization

Citations

This map shows the geographic impact of Jinjun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjun Cheng more than expected).

Fields of papers citing papers by Jinjun Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjun Cheng. The network helps show where Jinjun Cheng may publish in the future.

Co-authorship network of co-authors of Jinjun Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jinjun Cheng. A scholar is included among the top collaborators of Jinjun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinjun Cheng. Jinjun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Jinjun, R Mariani, Metin Özdemirli, et al.. (2024). Clinical and pathological features of pediatric peripheral T-cell lymphoma after solid organ transplantation. PubMed. 1(4). 100039–100039.

Dehner, L P, et al.. (2024). Sarcomatoid Morphology in Pediatric Langerhans Cell Neoplasm Does Not Always Predict Aggressive Clinical Course. Pediatric and Developmental Pathology. 28(1). 68–73.

Cheng, Jinjun, Birte Wistinghausen, & A. Yasmine Kirkorian. (2024). Pediatric Cutaneous T‐Cell Neoplasms: Clinical and Pathological Features, Updated Classifications, and Critical Differential Diagnoses. Pediatric Dermatology. 42(1). 11–21.

Cheng, Jinjun, et al.. (2024). Pediatric cutaneous T‐cell neoplasm and mimics with gamma‐delta expression: Not always aggressive. Pediatric Blood & Cancer. 71(3). e30837–e30837. 1 indexed citations

Cheng, Jinjun, Yannan Wang, Shunyou Gong, et al.. (2024). Pediatric T-lymphoblastic Leukemia With an Entirely Mature Immunophenotype: A Prompt and Challenging Diagnosis. Journal of Pediatric Hematology/Oncology. 47(1). e58–e61. 1 indexed citations

Cheng, Jinjun, Nikolaos Svoronos, Miao Pan, et al.. (2024). Philadelphia chromosome‐like B‐acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation. Pediatric Blood & Cancer. 71(6). e30963–e30963.

Cheng, Jinjun, Zhu Guo, Miao Pan, et al.. (2023). Pediatric Histiocytic Disorders: Morphology, Immunophenotype and Genetics. 3(4). 151–159. 2 indexed citations

Cheng, Jinjun & Birte Wistinghausen. (2023). Clinicopathologic Spectrum of Pediatric Posttransplant Lymphoproliferative Diseases Following Solid Organ Transplant. Archives of Pathology & Laboratory Medicine. 148(9). 1052–1062. 3 indexed citations

Ganguly, Debolina, Chun Cai, Michelle Sims, et al.. (2019). APELA Expression in Glioma, and Its Association with Patient Survival and Tumor Grade. Pharmaceuticals. 12(1). 45–45. 22 indexed citations

10.

Cheng, Jinjun, et al.. (2018). Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions. Pediatric Blood & Cancer. 66(1). e27453–e27453. 8 indexed citations

11.

Cheng, Jinjun, et al.. (2018). Chronic myeloid leukemia, BCR‐ABL1‐positive with CALR and MPL mutations. International Journal of Laboratory Hematology. 40(3). e41–e42. 5 indexed citations

12.

Cheng, Jinjun, et al.. (2018). Recurrent Cytogenetic Abnormalities in Intravascular Large B-Cell Lymphoma. American Journal of Clinical Pathology. 150(1). 18–26. 9 indexed citations

13.

Dang, Julie, Jing Ma, Jinjun Cheng, et al.. (2017). AMKL chimeric transcription factors are potent inducers of leukemia. Leukemia. 31(10). 2228–2234. 23 indexed citations

14.

Yang, Chuan, Yinan Wang, Michelle Sims, et al.. (2017). MicroRNA203a suppresses glioma tumorigenesis through an ATM-dependent interferon response pathway. Oncotarget. 8(68). 112980–112991. 22 indexed citations

15.

Cheng, Jinjun, Haiqing Zhu, & John Choi. (2017). CD30 Expression in Pediatric Neoplasms, Study of 585 Cases. Pediatric and Developmental Pathology. 20(3). 191–196. 10 indexed citations

16.

Yang, Chuan, Yinan Wang, Michelle Sims, et al.. (2016). MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis. Oncotarget. 7(51). 84017–84029. 19 indexed citations

17.

Wong, Jasmine C., Scott C. Kogan, Michael R. Burgess, et al.. (2015). Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis. eLife. 4. 15 indexed citations

18.

Dang, Jinjun, Lei Wei, Jeroen de Ridder, et al.. (2015). PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia. Blood. 125(23). 3609–3617. 53 indexed citations

19.

Radtke, Ina, Charles G. Mullighan, Masami Ishii, et al.. (2009). Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proceedings of the National Academy of Sciences. 106(31). 12944–12949. 128 indexed citations

20.

Hou, Jinlin, et al.. (1999). T₁₇₆₂/A₁₇₆₄ variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients. Liver International. 19(5). 411–417. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact